ChemicalBook > CAS DataBase List > Enibarcimab
Enibarcimab
- Product Name
- Enibarcimab
- CAS No.
- 2305638-98-4
- Chemical Name
- Enibarcimab
- Synonyms
- Enibarcimab;Research Grade Enibarcimab;Anti-Human ADM(Enibarcimab);Enibarcimab (anti-Adrenomedullin);Research Grade Enibarcimab(DHE09501)
- CBNumber
- CB810617038
- Formula Weight
- 0
- MOL File
- Mol file
More
Less
Enibarcimab Property
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Enibarcimab Chemical Properties,Usage,Production
Uses
Enibarcimab is a humanised murine monoclonal immunoglobulin G1 (IgG1) antibody, could be used for acute heart failure, COVID-19 infections and septic shock research[1].
References
[1] James E, et al. The Immune System and Chronic Heart Failure: Is the Heart in Control? Journal of the American College of Cardiology. 2019. 53(12):1013-1020.
Enibarcimab Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Enibarcimab Suppliers
- Tel
- 021-61312847; 18021002903
- Fax
- QQ:3008007432
- 3008007409@qq.com
- Country
- China
- ProdList
- 71826
- Advantage
- 60
- Tel
- 021-58180488
- Fax
- 021-58180499
- sales@MedChemLeader.com
- Country
- China
- ProdList
- 1006
- Advantage
- 58
- Tel
- 15817493340
- 981810490@qq.com
- Country
- China
- ProdList
- 1566
- Advantage
- 58
- Tel
- 027-65317797 15926423062
- Fax
- QQ:422450190
- 422450190@qq.com
- Country
- China
- ProdList
- 10308
- Advantage
- 58
- Tel
- 4008200310
- marketing@tsbiochem.com
- Country
- China
- ProdList
- 24961
- Advantage
- 58
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com
- Country
- China
- ProdList
- 9868
- Advantage
- 58
- Tel
- 0573-83568680 18057391398
- 3956524501@qq.com
- Country
- China
- ProdList
- 1442
- Advantage
- 58
- Tel
- 027-87008169 17762441161
- info@atagenix.com
- Country
- China
- ProdList
- 10001
- Advantage
- 58
- Tel
- 33175446423
- support@antibodysystem.com
- Country
- China
- ProdList
- 6739
- Advantage
- 58
- Tel
- 51288865780
- sales@biosynth.com
- Country
- China
- ProdList
- 6051
- Advantage
- 58
2305638-98-4, EnibarcimabRelated Search:
Sotrovimab
Ocrelizumab
Pritumumab
Bimagrumab
Emapalumab
Robatumumab
Anetumab Ravtansine
Research Grade Cantuzumab (DHD14203)
Panobacumab
Amatuximab